provides the cumulative proportion of the probability of survivors at the end of a particular time period.
IN.PACT Admiral SFA Japan demonstrated 93.9 percent primary patency in the DCB group as compared to 46.9 percent in the PTA group at one year based on Kaplan-Meier Estimate
showed that no differences in survival were exhibited in the challenge bioassay (Fig.
The gray area is the 95% confidence band for the Kaplan-Meier estimate
However, the end of a relapse-free survival given by the Kaplan-Meier estimate
should be valued with caution due to the large confidence interval.
Progression-free survival was not yet reached, but based on the Kaplan-Meier estimate
, the progression-free survival rate at 18 months was 90%.
At Kaplan-Meier estimate
, statistically significant association was observed with incidence of pregnancy at p value < 0.05.
As the usual Kaplan-Meier estimate
cannot be interpreted as probability in the presence of competing risks, the cumulative incidence function (CIF) as an alternative, that accounted for the competing risks and has a reasonable interpretation, was first suggested by .
about 14 weeks), according to a Kaplan-Meier estimate
. With methotrexate, the median time to flare was more than 32 weeks and about 20 weeks, respectively.
The Kaplan-Meier estimate
for 50% survival was 4.5 days.
The absolute 5-year risk of nonfatal MI was 5%; the risk for MI or vascular death was 16%; and the risk for recurrent stroke, HI, or vascular death was 25%, according to a Kaplan-Meier estimate